Antonella Isacchi Selected Research

Antonella Isacchi Research Topics

Disease

34	Neoplasms (Cancer) 11/2020 - 07/2005
5	Colorectal Neoplasms (Colorectal Cancer) 08/2017 - 12/2014
3	Carcinogenesis 11/2016 - 04/2010
3	Neoplasm Metastasis (Metastasis) 01/2016 - 07/2013
3	Melanoma (Melanoma, Malignant) 01/2016 - 07/2013
2	Chordoma 01/2018 - 01/2017
2	Brain Neoplasms (Brain Tumor) 04/2016 - 07/2013
2	Hematologic Neoplasms (Hematological Malignancy) 04/2012 - 09/2007
2	Carcinoma (Carcinomatosis) 08/2009 - 03/2007
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 05/2015
1	Glioma (Gliomas) 01/2015
1	Genetic Translocation (Chromosomal Translocation) 12/2014
1	Disease Progression 07/2013
1	Colonic Neoplasms (Colon Cancer) 04/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2012
1	Aneuploidy (Aneuploid) 12/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2010
1	Leukemia 08/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2007
1	Inflammation (Inflammations) 10/2004

Drug/Important Bio-Agent (IBA)

18	Phosphotransferases (Kinase)IBA 11/2020 - 10/2004
9	Pharmaceutical PreparationsIBA 01/2017 - 07/2005
7	Proteins (Proteins, Gene)FDA Link 08/2017 - 02/2012
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2010
4	entrectinibIBA 04/2016 - 12/2015
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 04/2016
3	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2017
2	Brachyury protein (Brachyury)IBA 01/2018 - 01/2017
2	Polo-Like Kinase 1IBA 01/2018 - 04/2012
2	Anaplastic Lymphoma KinaseIBA 04/2016 - 12/2015
2	CrizotinibIBA 04/2016 - 01/2016
2	TropomyosinIBA 01/2016 - 08/2010
2	Calcibiotic Root Canal SealerIBA 01/2016 - 12/2015
2	Adenosine Triphosphatases (ATPase)IBA 09/2013 - 02/2012
2	Biological ProductsIBA 03/2013 - 02/2012
2	danusertibIBA 02/2012 - 09/2007
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2010 - 05/2010
2	Aurora KinasesIBA 04/2010 - 09/2007
1	olaparibIBA 04/2019
1	niraparibIBA 04/2019
1	talazoparibIBA 04/2019
1	rucaparibIBA 04/2019
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	AfatinibIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 09/2016
1	alectinibIBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	ceritinibIBA 01/2016
1	IsoindolesIBA 09/2015
1	PyrrolesIBA 05/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2015
1	Dihydrotachysterol (AT 10)IBA 02/2015
1	Mitogen-Activated Protein KinasesIBA 02/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2014
1	compound 18IBA 11/2013
1	NMS-873IBA 09/2013
1	NMS-E973IBA 07/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2012
1	NMS P937IBA 04/2012
1	N- (2,6- diethylphenyl)- 1- methyl- 8- ((4- ((1- methylpiperidin- 4- yl)carbamoyl)- 2- (trifluoromethoxy)phenyl)amino)- 4,5- dihydro- 1H- pyrazolo(4,3- h)quinazoline- 3- carboxamideIBA 12/2010
1	Small Interfering RNA (siRNA)IBA 10/2010
1	rho-Associated KinasesIBA 08/2010
1	fasudil (AT 877)IBA 08/2010
1	N,1,4,4- tetramethyl- 8- ((4- (4- methylpiperazin- 1- yl)phenyl)amino)- 4,5- dihydro- 1H- pyrazolo(4,3- h)quinazoline- 3- carboxamideIBA 08/2010
1	CarcinogensIBA 08/2010
1	Retinoblastoma ProteinIBA 08/2010
1	N- (6,6- dimethyl- 5- ((1- methylpiperidin- 4- yl)carbonyl)- 1,4,5,6- tetrahydropyrrolo(3,4- c)pyrazol- 3- yl)- 3- methylbutanamideIBA 05/2010
1	EnzymesIBA 04/2010
1	Antineoplastic Agents (Antineoplastics)IBA 03/2010
1	PHA 767491IBA 06/2008
1	Imatinib Mesylate (Gleevec)FDA Link 09/2007
1	Proto-Oncogene Proteins c-metIBA 11/2005

Therapy/Procedure

12	Therapeutics 01/2018 - 09/2007
3	Oral Administration 01/2016 - 08/2010
1	Aftercare (After-Treatment) 03/2007